Picture of Bonk logo

BNKK — Bonk News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapValue Trap

Brief: Safety Shot Continues Scientific Development with Double-Blind Placebo-Controlled Trial Designed to Assess the Effects of Safety Shot on Blood and Breath Alcohol Levels

Nov 24 (Reuters) - Safety Shot Inc  SHOT.O :
    * SAFETY SHOT CONTINUES SCIENTIFIC DEVELOPMENT WITH
DOUBLE-BLIND
PLACEBO-CONTROLLED TRIAL DESIGNED TO ASSESS THE EFFECTS OF
SAFETY SHOT ON BLOOD AND BREATH ALCOHOL LEVELS
    * SAFETY SHOT INC - PLANS TO LAUNCH BUSINESS-TO-BUSINESS
SALES OF
SAFETY SHOT TO DISTRIBUTORS, RETAILERS, RESTAURANTS, AND BARS IN
Q1 OF 2024
    * SAFETY SHOT INC: SAFETY SHOT CLINICAL TRIAL TOPLINE DATA
EXPECTED Q1 2024

Source text for Eikon:  ID:nGNX1DkYJn 
Further company coverage:  SHOT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Bonk

See all news